The paper introduces a supervised algebraic counting field (ACF) that predicts cryptic ligand‑binding pocket residues from apo protein structures by compiling geometric, physicochemical, and topological features into compact integer‑weighted lookup tables. ACF allows each prediction score to be reconstructed from feature values, training counts, table weights, and spatial aggregation, eliminating the need for sequence search, structural‑template transfer, or a protein language model during inference. In benchmark tests on CryptoBench and external datasets, ACF outperformed the P2Rank method in mean paired ROC‑AUC on one external set, though gains varied across datasets and were not universally confirmed.
arXiv:2610.04850v2 Announce Type: replace Abstract: Protein binding prediction is central to target identification, therapeutic binder design, and large scale screening, yet remains challenging becau...
ProbeMatchDTI is a new framework for drug‑target interaction prediction that uses probe‑driven pattern matching to preserve weak biochemical signals. It introduces IterProbe, which retains contextual states across refinement depths and selects them with learnable probes, and BindingProbe, which models drug‑protein complementarity at both local and whole‑pair levels. Experiments show that ProbeMatchDTI outperforms existing methods, improving AUC‑ROC by 2.0% on BindingDB and 0.5% on DrugBank, and its predictions can be integrated into downstream drug‑discovery workflows.
ProbeMatchDTI introduces a probe-driven framework for drug‑target interaction prediction that preserves weak biochemical signals by using IterProbe to retain contextual states and BindingProbe to model cross‑entity complementarity at multiple scales. The method improves AUC‑ROC by 2.0% on BindingDB and 0.5% on DrugBank compared to prior biochemical representation learning approaches. Feature‑level analyses confirm the effectiveness of the probe-driven pattern matching, and the predictions are linked to an evidence‑guided downstream drug‑discovery workflow for candidate refinement and validation planning.
The paper introduces a scalable method to interpret sparse autoencoder (SAE) features in the ESM-2 protein language model by leveraging geometrically inspired features of the protein α‑carbon backbone. Across 8M layers of ESM-2, a false discovery rate–controlled analysis shows that local geometry is significantly associated with many SAE features, revealing substructure within known biological labels and enabling annotation of unannotated metagenomic proteins. Ablation experiments demonstrate that removing these geometric features shifts ESM-2’s predicted contact maps toward the descriptor, linking mechanistic interpretability with structural biology.
The paper introduces Prompteina, an all‑atom protein structure generation model that accepts natural‑language descriptions of desired structural and functional properties, similar to text‑to‑image systems. It is trained on a large paired dataset of 1.8 million protein structures and over 50 million captions, and fine‑tuned from the Proteina‑Complexa model to align residues with textual cues. Prompteina outperforms existing baselines on most structural metrics, improves binder design performance, and experimentally validates nine new binders for the GM2A target.
arXiv:2608. 09099v1 Announce Type: new Abstract: Quantitative estimation of protein-ligand binding affinity from three-dimensional complex structures is a fundamental task in structure-based computational chemistry and molecular modeling.
arXiv:2605. 01625v3 Announce Type: replace Abstract: Proteins are inherently multiscale physical systems whose functional properties emerge from coordinated structural organization across multiple spatial resolutions, ranging from atomic interactions to global fold topology.
arXiv:2609.36277v1 Announce Type: new Abstract: Existing protein geometry models typically represent molecular surfaces using local geometric features such as sampled points, normals, and curvature....
arXiv:2607. 28553v1 Announce Type: new Abstract: Predicting the 3D structures of atomic systems is fundamental to advancing material science and drug discovery.
arXiv:2604.18467v3 Announce Type: replace-cross Abstract: Motivation: Peptide-protein interactions (PepPIs) are central to cellular regulation and peptide therapeutics, but experimental characterizat...
arXiv:2606. 04020v1 Announce Type: cross Abstract: Splice-mediated drug resistance occurs in up to 40% of patients on targeted kinase inhibitors, yet state-of-the-art druggability tools operate on single structures and cannot compare across isoforms.
TopU-LBVS is a new multi‑target benchmark for ligand‑based virtual screening that addresses shortcomings of existing datasets by using hard‑negative decoys and a fixed 1:40 active‑to‑decoy ratio. It covers 93 protein targets across seven classes, provides three evaluation protocols (full, low‑data, and mini), and includes curated ChEMBL‑35 bioactivity data with property‑matched, structurally similar decoys. The benchmark demonstrates that performance drops sharply when moving from random‑decoy to hard‑negative evaluation, and it releases data, splits, code, and baseline implementations for reproducible comparison.